Evaluation of quality of life, side effects and duration of therapy in a phase 3 study of intermittent monotherapy versus continuous combined androgen deprivation

F.E. Calais Da Silva, F. Goncalves, A. Santos, J. Kliment, F.M. Calais Da Silva, P. Whelan, T. Oliver, C. Robertson

Research output: Contribution to journalArticlepeer-review

Abstract

Introduction & Objectives: We propose this Phase III study comparing the intermittent monotherapy with continuous combined androgen deprivation using an LHRH analogue and ciproterone acetate and associated components of quality of life.
Original languageEnglish
Pages (from-to)205-205
Number of pages0
JournalEuropean Urology Supplements
Volume7
Issue number3
DOIs
Publication statusPublished - Mar 2008

Keywords

  • evaluation
  • quality of life
  • side effects
  • duration of therapy
  • phase 3 study
  • intermittent monotherapy
  • versus
  • continuous combined androgen deprivation

Cite this